Cargando…
1914. Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B.1.1.529 In a Comprehensive Cancer Center
BACKGROUND: SARS-CoV-2 B.1.1.529 (Omicron) variant was first identified in November 2021 in South Africa and was notable for its increased transmissibility and rapid spread worldwide. In the United States, this variant led to a surge in COVID-19 cases by December 2021. As a result, we experienced a...
Autores principales: | Dib, Rita Wilson, Spallone, Amy, Khawaja, Fareed, Bartek, Jalen, Cantu, Sherry, Dvorak, Tanya, Feldman, Adina, McMurry, Hilary, Nahavandi, Leila, Nguyen, Kim, Odom, Crystal, Hankins, Amy, Gravis, Linda, Chemaly, Roy F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752466/ http://dx.doi.org/10.1093/ofid/ofac492.1541 |
Ejemplares similares
-
Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
por: Khawaja, Fareed, et al.
Publicado: (2023) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
por: Grüne, Barbara, et al.
Publicado: (2022) -
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
por: Chun, June Young, et al.
Publicado: (2022)